ValuEngine upgraded shares of Cyanotech (NASDAQ:CYAN) from a sell rating to a hold rating in a report released on Monday, April 2nd.
CYAN traded up $0.07 during trading on Monday, reaching $4.27. The stock had a trading volume of 5,318 shares, compared to its average volume of 12,929. The company has a market capitalization of $29.05, a price-to-earnings ratio of 16.29 and a beta of 0.64. The company has a debt-to-equity ratio of 0.31, a current ratio of 2.44 and a quick ratio of 0.85. Cyanotech has a 1-year low of $3.25 and a 1-year high of $5.78.
Cyanotech (NASDAQ:CYAN) last released its earnings results on Tuesday, February 6th. The biotechnology company reported $0.19 earnings per share for the quarter. The firm had revenue of $9.15 million during the quarter. Cyanotech had a return on equity of 10.23% and a net margin of 5.44%.
Cyanotech Company Profile
Cyanotech Corporation is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The Company’s products include Hawaiian Spirulina Pacifica and Hawaiian BioAstin. Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Cyanotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyanotech and related companies with MarketBeat.com's FREE daily email newsletter.